SCHEMBL17948781

SCHEMBL17948781

CN(C)c1ccc(-c2sc(CN)nc2C(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 1/20 0.42
▸ PTPN2 P17706 1/20 0.42
▸ PTPN1 P18031 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.40
▸ AOC3 Q16853 2/20 0.38
▸ TOP1 P11387 2/20 0.37
▸ DDX3X O00571 1/20 0.37
▸ GPR52 Q9Y2T5 1/20 0.36
▸ MGAM O43451 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ SI P14410 1/20 0.36
▸ MGAM2 Q2M2H8 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ APP P05067 2/20 0.35
▸ GLS O94925 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17948786 0.81 KDM4E (0.53) PTPN1PTGDR2GAAALDH1A1MEN1
SCHEMBL17949048 0.81 FBP1 (0.37) ALDH1A1HSD17B10CYP1A2CYP2C9MEN1
SCHEMBL17949007 0.77 HSD17B3 (0.41) APPMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL17948791 0.70 NR4A2 (0.39) PTPN2PTPN1PTGDR2AOC3TOP1
SCHEMBL27789562 0.69 KDM4E (0.47) GAAALDH1A1HSD17B10CYP1A2CYP2C9
SCHEMBL1258223 0.69 MAPK14 (0.45) PTGDR2ALDH1A1HSD17B10CYP1A2CYP2C9
SCHEMBL27834590 0.69 KDM4E (0.44) GAAALDH1A1HSD17B10CYP1A2CYP2C9
SCHEMBL980993 0.68 ALDH1A1 (0.47) GAAALDH1A1HSD17B10CYP1A2MEN1
SCHEMBL13398494 0.68 KDM4E (0.46) GAAALDH1A1HSD17B10CYP1A2CYP2C9
SCHEMBL984151 0.68 MAPK14 (0.41) PTGDR2ALDH1A1HSD17B10CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230046194-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-02-16 — — US disclosed
US-20200370057-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-11-26 — — US disclosed
US-10745705-B2 Ribosome-mediated incorporation of peptides and peptidomimetics ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-08-18 — — US disclosed
US-20180002709-A1 RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-01-04 — — US disclosed
WO-2016118877-A1 RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2016-07-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002709-A1 RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS NPEPPS, DNPEP, AARS1 PTPRC 1967/4885PTPN2 1472/4885PTPN1 1363/4885
US-20200370057-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics NPEPPS, DNPEP, AARS1 PTPRC 1967/4885PTPN2 1472/4885PTPN1 1363/4885
US-20230046194-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics NPEPPS, DNPEP, AARS1 PTPRC 1967/4885PTPN2 1472/4885PTPN1 1363/4885
US-10745705-B2 Ribosome-mediated incorporation of peptides and peptidomimetics NPEPPS, DNPEP, AARS1 PTPRC 1967/4885PTPN2 1472/4885PTPN1 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback